| Literature DB >> 32611930 |
Fumihiro Miyashita1, Takeshi Kinoshita1, Tomoaki Suzuki1, Tohru Asai1.
Abstract
PURPOSE: This study was conducted to identify predictors of respiratory failure after open repair of descending thoracic aortic aneurysm (DTAA), and to identify any relationship between respiratory failure and long-term survival.Entities:
Keywords: aortic aneurysm; descending thoracic aortic aneurysm; open repair; preoperative pulmonary function; respiratory failure
Year: 2020 PMID: 32611930 PMCID: PMC8043027 DOI: 10.5761/atcs.oa.20-00020
Source DB: PubMed Journal: Ann Thorac Cardiovasc Surg ISSN: 1341-1098 Impact factor: 1.520
Preoperative and intraoperative patient demographics
| All (n = 75) | Respiratory failure (n = 11) | No respiratory failure (n = 64) | ||
|---|---|---|---|---|
| Preoperative | ||||
| Age, years | 69 [57–75] | 62 [53–80] | 69 [58–75] | 0.595 |
| Age ≥70 years | 32 (42.6) | 3 (27.2) | 29 (45.3) | 0.263 |
| Female gender | 14 (18.6) | 2 (18.1) | 12 (18.7) | 0.964 |
| Body mass index, kg/m2 | 23.3 [20.5–26.0] | 22.5 [20.5–26.0] | 23.4 [20.5–25.9] | 0.784 |
| Smoking history | 54 (72.0) | 9 (81.8) | 45 (70.3) | 0.432 |
| Diabetes mellitus | 12 (16.0) | 3 (27.2) | 9 (14.0) | 0.269 |
| Hypertension | 57 (76.0) | 4 (36.3) | 53(82.8) | 0.001 |
| Serum creatinine, mg/dL | 0.93 [0.77–1.29] | 0.79 [0.69–1.02] | 0.99 [0.78–1.31] | 0.123 |
| FEV1%, % | 71.6 [64.8–76.4] | 70.3 [58.9–74.5] | 71.6 [65.6–76.7] | 0.154 |
| Vital capacity, % | 96.2 [83.4–112] | 85.9 [82.1–116] | 97.0 [84.6–112] | 0.150 |
| Marfan syndrome | 4 (5.3) | 1 (9.1) | 3 (4.6) | 0.477 |
| Cause | ||||
| Degenerative aneurysm | 29 (38.7) | 2 (18.2) | 27 (42.1) | 0.131 |
| Chronic post-dissection aneurysm | 41 (54.7) | 7 (63.6) | 34 (53.1) | 0.518 |
| Pseudoaneurysm | 3 (4.0) | 1 (9.1) | 2 (3.1) | 0.383 |
| Re-expansion after TEVAR | 2 (2.7) | 1 (9.1) | 1 (1.6) | 0.274 |
| Proximal extent of aortic replacement | ||||
| Zone 3 | 27 (36.0) | 3 (27.2) | 24 (37.5) | 0.514 |
| Zone 4 | 48 (64.0) | 8 (72.7) | 40 (62.5) | 0.514 |
| T4 | 23 (30.7) | 6 (54.5) | 17 (26.6) | 0.063 |
| T5 | 7 (9.3) | 1 (9.1) | 6 (9.4) | 0.976 |
| T6 | 5 (6.7) | 0 (0) | 5 (7.8) | 0.442 |
| T7 | 5 (6.7) | 0 (0) | 5 (7.8) | 0.442 |
| T8 | 3 (4.0) | 0 (0) | 3 (4.7) | 0.617 |
| T9 | 2 (2.7) | 1 (9.1) | 1 (1.6) | 0.274 |
| T10 | 3 (4.0) | 0 (0) | 3 (4.7) | 0.617 |
| EuroSCORE II, % | 3.39 [2.11–6.42] | 3.76 [2.88–6.42] | 3.18 [2.08–6.35] | 0.574 |
| Previous aortic repair | 38 (50.6) | 7 (63.6) | 31 (48.4) | 0.352 |
| Open surgery | 45 | 7 | 8 | |
| Aortic root | 1 (1.3) | 0 (0) | 1 (1.5) | 0.853 |
| Ascending aorta | 13 (17.3) | 3 (27.2) | 10 (15.6) | 0.346 |
| Arch | 19 (25.3) | 4 (36.3) | 15 (23.4) | 0.362 |
| Descending aorta | 3 (4.0) | 0 (0) | 3 (4.7) | 0.617 |
| Abdominal aorta | 9 (12.0) | 0 (0) | 9 (14.0) | 0.184 |
| Endovascular repair | 3 | 1 | 2 | |
| Descending aorta | 3 (6.0) | 1 (9.1) | 2 (3.1) | 0.383 |
| Intraoperative | ||||
| Operation time, minutes | 266 [201–323] | 327 [294–358] | 252 [193–296] | 0.001 |
| Bypass time, minutes | 88 [54–146] | 173 [114–198] | 79 [51–138] | 0.004 |
| Hypothermic circulatory arrest | 27 (36.0) | 7 (63.6) | 20 (31.3) | 0.039 |
| Intercostal arteries reconstruction | 5 (6.7) | 0 (0) | 5 (7.8) | 0.442 |
| Transfusion | 49 (65.3) | 11 (100) | 38 (59.4) | 0.009 |
Categorical data are presented as n (%) and continuous data as median [interquartile range]. EuroSCORE: European System for Cardiac Operative Risk Evaluation; FEV1% = (forced expiratory volume in 1 second/forced vital capacity) × 100; TEVAR: thoracic endovascular aortic repair
Early outcomes
| All (n = 75) | Respiratory failure (n = 11) | No respiratory failure (n = 64) | ||
|---|---|---|---|---|
| 30-day mortality | 0 (0) | 0 (0) | 0 (0) | – |
| In-hospital mortality | 2 (2.7) | 2 (18.2) | 0 (0) | 0.020 |
| Tracheostomy | 5 (6.7) | 5 (45.5) | 0 (0) | <0.001 |
| Pneumonia | 4 (5.3) | 3(27.3) | 1 (1.6) | 0.009 |
| Pleural effusion requiring drainage | 22 (29.3) | 8 (72.7) | 14 (21.9) | 0.001 |
| Chylothorax | 6 (8.0) | 2 (18.2) | 4 (6.3) | 0.178 |
| Reintubation | 5 (6.7) | 4 (36.4) | 1 (1.6) | 0.001 |
| Stroke | 5 (6.7) | 2 (18.2) | 3 (4.7) | 0.153 |
| Paraplegia or paraparesis | 3 (4.0) | 1 (9.1) | 2 (3.1) | 0.383 |
| Bleeding necessitating reoperation | 5 (6.7) | 1 (9.1) | 4 (6.3) | 0.558 |
| Wound dehiscence | 10 (13.3) | 2 (18.2) | 8 (12.5) | 0.609 |
| Wound infection | 4 (5.3) | 1 (9.1) | 3 (4.7) | 0.477 |
| Length of stay, days | 23 [17–39] | 50 [31–137] | 22 [17–34] | 0.001 |
Categorical data are presented as n (%) and continuous data as median [interquartile range].
Univariate and multivariate models of the incidence of postoperative respiratory failure in relation to baseline and operative value
| Variable | Univariate model | Multivariate model | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | Odds ratio (95% CI) | |||
| Age, years (10-year increments) | 0.82 (0.49–1.38) | 0.453 | 0.70 (0.33–1.48) | 0.352 |
| Sex | ||||
| Female | 1 [Reference] | |||
| Male | 1.04 (0.20–5.44) | 0.964 | ||
| Body mass index, kg/m2 | 1.07 (0.91–1.25) | 0.416 | ||
| Diabetes mellitus | ||||
| No | 1 [Reference] | |||
| Yes | 2.29 (0.51–10.2) | 0.279 | ||
| Hypertension | ||||
| No | 1 [Reference] | 1 [Reference] | ||
| Yes | 0.12 (0.03–0.48) | 0.003 | 0.06 (0.01–0.57) | 0.014 |
| Dyslipidemia | ||||
| No | 1 [Reference] | |||
| Yes | 0.19 (0.02–1.59) | 0.126 | ||
| Previous aortic repair | ||||
| No | 1 [Reference] | |||
| Yes | 1.86 (0.50–6.99) | 0.357 | ||
| Marfan syndrome | ||||
| No | 1 [Reference] | |||
| Yes | 2.03 (0.19–21.5) | 0.556 | ||
| Preoperative Serum creatinine, mg/dL | 0.69 (0.20–2.36) | 0.552 | ||
| EuroSCORE II, % | 1.02 (0.88–1.18) | 0.773 | ||
| Smoking history | ||||
| No | 1 [Reference] | 1 [Reference] | ||
| Yes | 1.90 (0.38–9.63) | 0.438 | 15.7 (0.89–278) | 0.060 |
| Vital capacity, % (10% decrement) | 1.26 (0.90–1.77) | 0.181 | 1.45 (0.92–2.30) | 0.113 |
| FEV1%, % (10% decrement) | 1.55 (0.88–2.71) | 0.129 | 3.69 (1.24–11.0) | 0.019 |
| Operation time, minutes (10-minute increments) | 1.15 (1.05–1.25) | 0.003 | 1.18 (1.03–1.35) | 0.017 |
| Hypothermic circulatory arrest | ||||
| No | 1 [Reference] | 1 [Reference] | ||
| Yes | 3.85 (1.01–14.7) | 0.048 | 1.46 (0.18–11.9) | 0.723 |
EuroSCORE: European System for Cardiac Operative Risk Evaluation; FEV1%: (forced expiratory volume in 1 second/forced vital capacity) × 100
Multivariate analysis of risk factors for long-term survival
| Variable | Hazard ratio (95% CI) | |
|---|---|---|
| Age, years (per year) | 1.08 (1.01–1.16) | 0.032 |
| Hypertension | 0.70 (0.09–5.80) | 0.745 |
| Smoking history | 1.31 (0.20–8.57) | 0.781 |
| Vital capacity, % (10% decrement) | 1.05 (0.73–1.51) | 0.786 |
| FEV1%, % (10% decrement) | 1.04 (0.97–1.12) | 0.299 |
| Operation time, minutes (10-minute increments) | 1.00 (0.99–1.01) | 0.656 |
| Hypothermic circulatory arrest | 2.67 (0.37–19.1) | 0.328 |
| Postoperative respiratory failure | 5.79 (1.58–21.2) | 0.008 |
FEV1%: (forced expiratory volume in 1 second/forced vital capacity) × 100